The primary goal of the Protocol Review and Monitoring Committee (PRMC) is to ensure that all cancerrelated clinical research studies involving human subjects that are conducted within Washington University Medical Center are scientifically evaluated and prioritized by the Siteman Cancer Center (SCC), Studies that do not have prior NCI review (institutional and industry-initiated studies) are reviewed by the full PRMC to ensure that they are (1) scientifically and statistically sound, (2) appropriately designed, (3) feasible for completion, (4) prioritized by the appropriate research working group(s), and (5) in compliance with NIH guidelines for clinical trials, including monitoring for accrual and undue toxicity (if applicable). Studies that have received prior NCI review (primarily cooperative group studies) are reviewed administratively (by PRMC Co-Chairs) to ensure that they have been prioritized by the appropriate research working group(s), and that all SCC guidelines have been addressed, as appropriate. For the purposes of this committee, a cancer research study is defined as a formal research plan that: (1) is intended to evaluate an untested, unproven or unknown regimen or procedure for the screening, diagnosis, staging, treatment, support, outcome, prevention, control, or characterization of human subjects in regard to cancer, or compares standard to unproven regimens or procedures, and (2) requires the approval ofthe Institutional Review Board (IRB). The PRMC is responsible for: Providing scientific peer-review for all investigator- and industry-initiated cancer research studies. Reviewing all active cancer research studies for renewal/termination (the Quality Assurance and Safety Monitoring Committee can independently close studies but report findings to the PRMC). Ensuring that all competing studies have been prioritized by the leadership ofthe appropriate research working group(s). Monitoring accrual in all active cancer research studies. Tracking and reporting information about study design and execution.

Public Health Relevance

The Protocol Review and Monitoring Committee (PRMC) ensures that all cancer-related clinical research studies involving human subjects that are conducted within Washington University Medical Center are scientifically evaluated and prioritized by the Siteman Cancer Center (SCC)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA091842-12
Application #
8520222
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
12
Fiscal Year
2013
Total Cost
$153,082
Indirect Cost
$53,162
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Choi, Jaebok; Cooper, Matthew L; Staser, Karl et al. (2018) Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease. Leukemia 32:2483-2494
Bartlett, Nancy L; Costello, Brian A; LaPlant, Betsy R et al. (2018) Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial. Blood 131:182-190
Mostafa, Heba H; Thompson, Thornton W; Konen, Adam J et al. (2018) Herpes Simplex Virus 1 Mutant with Point Mutations in UL39 Is Impaired for Acute Viral Replication in Mice, Establishment of Latency, and Explant-Induced Reactivation. J Virol 92:
Yokoyama, Christine C; Baldridge, Megan T; Leung, Daisy W et al. (2018) LysMD3 is a type II membrane protein without an in vivo role in the response to a range of pathogens. J Biol Chem 293:6022-6038
Miller, Jessica; Wang, Steven T; Orukari, Inema et al. (2018) Perfusion-based fluorescence imaging method delineates diverse organs and identifies multifocal tumors using generic near-infrared molecular probes. J Biophotonics 11:e201700232
Kalas, Vasilios; Hibbing, Michael E; Maddirala, Amarendar Reddy et al. (2018) Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection. Proc Natl Acad Sci U S A 115:E2819-E2828
Gauvain, Karen; Ponisio, Maria Rosana; Barone, Amy et al. (2018) 18F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors. Neurooncol Pract 5:28-36
Cruchaga, Carlos; Del-Aguila, Jorge L; Saef, Benjamin et al. (2018) Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement 14:205-214
Song, Wilbur M; Joshita, Satoru; Zhou, Yingyue et al. (2018) Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. J Exp Med 215:745-760
Staples, Robert; London, Daniel A; Dardas, Agnes Z et al. (2018) Comparative Morbidity of Cubital Tunnel Surgeries: A Prospective Cohort Study. J Hand Surg Am 43:207-213

Showing the most recent 10 out of 1244 publications